infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 676 articles from: Therapies

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Avalanche of hepatitis C products on the way

    Pharma Times / 04 April 2011

  • Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients

    Bloomberg / 04 April 2011

  • Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France

    Bloomberg / 04 April 2011

  • Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011

    Business Wire / 04 April 2011

  • First vaccine for viral hepatitis C could become a reality

    Eurekalert Inf Dis / 01 April 2011

  • Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189

    Pipeline Review / 01 April 2011

  • 'Fantastic' data on Novartis' first-in-class hep C antiviral

    Pharma Times / 01 April 2011

  • Well-known statin could be recycled as HCV therapy supplement

    EASL / 01 April 2011

  • Results From Phase 3 REALIZE Study Showed Telaprevir-Based Therapy Significantly Improved SVR (Viral Cure) Rates in People Whose Prior Treatment For Hepatitis C Was Unsuccessful

    Business Wire / 31 March 2011

  • Interim Phase 2 Data Showed Rapid Viral Response to VX-222 in Combination with Telaprevir, Pegylated-Interferon and Ribavirin Among People With Hepatitis C

    Business Wire / 31 March 2011

← Prev1...6465666768Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • HCV and coinfections
      • Living with HCV
      • Treatment issues
      • Side effects
      • Therapies
      • Liver transplants
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//